Dingemanse, J <br/><br/>
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  May 1995 
 - 508-17 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/0009-9236(95)90035-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Benzophenones--adverse effects<br/>Catechol O-Methyltransferase Inhibitors<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Half-Life<br/>Humans<br/>Intestinal Absorption<br/>Male<br/>Nitrophenols<br/>Tolcapone